Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Loncastuximab Tesirine in WM

NCT05190705

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Fred Hutch Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05057494

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Longmont, Colorado, United States
  • Research Site Jacksonville, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Conditions
Constriction, Pathologic, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Abrazo Arizone Heart Hospital Phoenix, Arizona, United States
  • HonorHealth Scottsdale Shea Medical Center Scottsdale, Arizona, United States
  • Los Robles Hospital & Medical Center Thousand Oaks, California, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

NCT04649359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UCLA Hematology/Oncology Clinic Los Angeles, California, United States
  • UC Irvine Health - Chao Family Comprehensive Cancer Center Orange, California, United States
View all 40 locations
View Trial Details

Related conditions